Round Rock Advisors LLC Acquires New Holdings in Omada Health, Inc. $OMDA

Round Rock Advisors LLC bought a new position in shares of Omada Health, Inc. (NASDAQ:OMDA) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 33,932 shares of the company’s stock, valued at approximately $745,000. Round Rock Advisors LLC owned 0.06% of Omada Health at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the company. Perceptive Advisors LLC bought a new position in shares of Omada Health in the second quarter worth $44,402,000. Millennium Management LLC increased its position in shares of Omada Health by 1,195.0% in the fourth quarter. Millennium Management LLC now owns 2,272,168 shares of the company’s stock worth $35,855,000 after purchasing an additional 2,096,705 shares during the last quarter. BlackRock Inc. purchased a new stake in Omada Health in the second quarter valued at approximately $48,775,000. Loomis Sayles & Co. L P lifted its position in Omada Health by 23.0% during the fourth quarter. Loomis Sayles & Co. L P now owns 1,855,721 shares of the company’s stock valued at $29,283,000 after purchasing an additional 346,588 shares during the last quarter. Finally, Jefferies Financial Group Inc. purchased a new position in Omada Health in the 4th quarter worth approximately $16,948,000.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on OMDA shares. Evercore restated an “outperform” rating and set a $20.00 price objective on shares of Omada Health in a research report on Friday, May 8th. BTIG Research increased their target price on Omada Health from $30.00 to $35.00 and gave the company a “buy” rating in a research note on Monday, August 10th. Citizens Jmp raised their price target on Omada Health from $27.00 to $32.00 and gave the company a “market outperform” rating in a research report on Friday, August 14th. Wall Street Zen raised Omada Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Finally, Citigroup reiterated an “outperform” rating on shares of Omada Health in a research report on Friday, August 14th. Eleven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Omada Health currently has an average rating of “Moderate Buy” and a consensus target price of $26.50.

Omada Health Stock Up 2.1%

Omada Health stock opened at $23.31 on Thursday. The firm has a fifty day simple moving average of $22.59 and a two-hundred day simple moving average of $17.46. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $26.92. The company has a market capitalization of $1.43 billion, a PE ratio of 466.20 and a beta of 1.86.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. Omada Health had a return on equity of 2.60% and a net margin of 1.39%.The firm had revenue of $87.83 million for the quarter, compared to analysts’ expectations of $80.93 million. As a group, equities analysts expect that Omada Health, Inc. will post 0.09 earnings per share for the current fiscal year.

Insider Activity at Omada Health

In other news, CFO Steven L. Cook sold 33,000 shares of the stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $19.89, for a total transaction of $656,370.00. Following the completion of the sale, the chief financial officer owned 133,359 shares of the company’s stock, valued at approximately $2,652,510.51. This represents a 19.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Sean P. Duffy sold 25,886 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $22.68, for a total transaction of $587,094.48. Following the completion of the transaction, the chief executive officer owned 411,861 shares in the company, valued at $9,341,007.48. This represents a 5.91% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 255,834 shares of company stock worth $5,398,196. 6.38% of the stock is owned by corporate insiders.

Omada Health Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.